Celcuity, Inc.

CELC Healthcare Biotechnology

In the quarter to June 2026, EPS fell 38.5%, free cash flow fell 53.3% and total debt rose 658.7%, each against the same quarter a year earlier.

56.16 4.14 −6.87%
Market cap
$3.0B
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Older periods Sep '25 Dec '25 Mar '26 Jun '26
Total current assets
475.50 465.66 408.93 775.84
Total non-current assets
0.51 0.90 1.24 52.38
Total Assets
476.00 466.56 410.16 828.22
Total current liabilities
38.79 44.15 33.21 86.87
Total non-current liabilities
320.25 321.85 323.43 754.13
Total liabilities
359.04 366.00 356.64 841.00
Common Equity (Total)
116.96 100.56 53.53 (12.78)
Shareholders Equity (Total)
116.96 100.56 53.53 (12.78)
Total Debt
320.25 321.85 323.43 753.24

Show all line items

In millions of $ except per-share values · columns are period end dates